Burney Company’s Corcept Therapeutics CORT Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.85M	Sell	45,779 -178,058	-80%	-$6.66M	0.06%	228
2025 Q4	$7.79M	Sell	223,837 -6,928	-3%	-$544K	0.24%	91
2025 Q3	$19.2M	Sell	230,765 -19,381	-8%	-$1.4M	0.61%	35
2025 Q2	$18.4M	Sell	250,146 -16,251	-6%	-$1.18M	0.62%	40
2025 Q1	$30.4M	Sell	266,397 -207,424	-44%	-$12.6M	1.11%	14
2024 Q4	$23.9M	Buy	473,821 +39,657	+9%	+$2.08M	0.84%	24
2024 Q3	$20.1M	Buy	434,164 +17,366	+4%	+$617K	0.71%	30
2024 Q2	$13.5M	Sell	416,798 -14,840	-3%	-$407K	0.52%	45
2024 Q1	$10.9M	Buy	431,638 +12,402	+3%	+$293K	0.41%	62
2023 Q4	$13.6M	Buy	419,236 +17,973	+4%	+$494K	0.57%	34
2023 Q3	$10.9M	Buy	401,263 +115,006	+40%	+$3.33M	0.51%	49
2023 Q2	$6.37M	Sell	286,257 -612	-0.2%	-$14.1K	0.29%	91
2023 Q1	$6.21M	Sell	286,869 -9,452	-3%	-$207K	0.31%	91
2022 Q4	$6.02M	Sell	296,321 -94,959	-24%	-$2.38M	0.3%	95
2022 Q3	$10M	Buy	391,280 +50,792	+15%	+$1.36M	0.55%	46
2022 Q2	$8.1M	Sell	340,488 -9,492	-3%	-$207K	0.43%	63
2022 Q1	$7.88M	Sell	349,980 -1,596	-0.5%	-$34K	0.36%	80
2021 Q4	$6.96M	Sell	351,576 -31,600	-8%	-$641K	0.3%	100
2021 Q3	$7.54M	Sell	383,176 -3,432	-0.9%	-$71.8K	0.35%	84
2021 Q2	$8.51M	Buy	386,608 +8,781	+2%	+$195K	0.4%	74
2021 Q1	$8.99M	Buy	377,827 +9,796	+3%	+$262K	0.44%	67
2020 Q4	$9.63M	Buy	368,031 +21,573	+6%	+$455K	0.53%	54
2020 Q3	$6.03M	Buy	346,458 +79,649	+30%	+$1.27M	0.37%	79
2020 Q2	$4.49M	Buy	+266,809	New	+$3.75M	0.29%	104